Intravitreal ranibizumab and dexamethasone implant injections as primary treatment of diabetic macular edema: simultaneously double protocol

PURPOSE: To assess the 12-month efficacy and safety of simultaneously administered intravitreal dexamethasone implant (DEX implant) and ranibizumab (simultaneous double protocol) injections in comparison with ranibizumab monotherapy as the first-line treatment of diabetic macular oedema (DMO). METHO...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eye (Lond)
Egile Nagusiak: Kaya, Mahmut, Kocak, Nilufer, Ozturk, Taylan, Bolluk, Volkan, Ayhan, Ziya, Kaynak, Suleyman
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027799/
https://ncbi.nlm.nih.gov/pubmed/32398852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-020-0949-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak